| 产品描述: | XD14 is a potent BET inhibitor with antitumor effect. It binds to BRD2, BRD3, and BRD4 with Kds of 170, 380, and 160 nM, respectively |
| 靶点: |
BRD2:170 nM (Kd);BRD3:380 nM (Kd);BRD4:160 nM (Kd) |
| 参考文献: |
1. Schäker-Hübner L, et al. 4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads. J Med Chem. 2021 Oct 14;64(19):14620-14646. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.372 ml |
11.862 ml |
23.724 ml |
| 5 mM |
0.474 ml |
2.372 ml |
4.745 ml |
| 10 mM |
0.237 ml |
1.186 ml |
2.372 ml |
| 50 mM |
0.047 ml |
0.237 ml |
0.474 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |